Deciphering the roles of macrophages in developmental and inflammation stimulated lymphangiogenesis

Vascular Cell

Volumn 4, Issue , 2012, Pages

  Harvey, Natasha L ^a   Gordon, Emma J ^b  

^a CENTRE FOR CANCER BIOLOGY   (Australia)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Development; Inflammation; Lymphangiogenesis; Macrophages; Monocytes; VEGF C; VEGF D

Indexed keywords

CD36 ANTIGEN; GELATINASE A; GELATINASE B; PROTEIN KINASE SYK; THROMBOSPONDIN 1; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CANCER MODEL; CELL LINEAGE; CELL TRANSPORT; EMBRYO DEVELOPMENT; GRANULOCYTE; HEMATOPOIETIC CELL; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; INFLAMMATION; INNATE IMMUNITY; LYMPH FLOW; LYMPH NODE; LYMPH VESSEL; LYMPHANGIOGENESIS; MACROPHAGE; METASTASIS INHIBITION; MONOCYTE; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE GROWTH; TUMOR MICROENVIRONMENT;

EID: 84866403566     PISSN: None     EISSN: 2045824X     Source Type: Journal    
DOI: 10.1186/2045-824X-4-15     Document Type: Review

References (82)

1. Trophic macrophages in development and disease. Pollard JW, Nat Rev Immunol 2009 9 259 270 10.1038/nri2528 19282852
2. The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. Nucera S, Biziato D, De Palma M, Int J Dev Biol 2011 55 495 503 10.1387/ijdb.103227sn 21732273
3. Metchnikoff's policemen: macrophages in development, homeostasis and regeneration. Stefater JA, Ren S, Lang RA, Duffield JS, Trends Mol Med 2011 17 743 752 10.1016/j.molmed.2011.07.009 21890411
4. Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Lang RA, Bishop JM, Cell 1993 74 453 462 10.1016/0092-8674(93)80047-I 8348612 (Pubitemid 23244611)
5. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, Ondr JK, Kurup S, Glass DA, Patel MS, Shu W, et al. Nature 2005 437 417 421 10.1038/nature03928 16163358 (Pubitemid 41613504)
6. Microglia promote the death of developing Purkinje cells. Marin-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M, Neuron 2004 41 535 547 10.1016/S0896-6273(04)00069-8 14980203 (Pubitemid 38253066)
7. Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. Van Nguyen A, Pollard JW, Dev Biol 2002 247 11 25 10.1006/dbio.2002.0669 12074549 (Pubitemid 34681162)
8. Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. Rae F, Woods K, Sasmono T, Campanale N, Taylor D, Ovchinnikov DA, Grimmond SM, Hume DA, Ricardo SD, Little MH, Dev Biol 2007 308 232 246 10.1016/j.ydbio.2007.05.027 17597598 (Pubitemid 47087792)
9. Dual roles for macrophages in ovarian cycle-associated development and remodelling of the mammary gland epithelium. Chua AC, Hodson LJ, Moldenhauer LM, Robertson SA, Ingman WV, Development 2010 137 4229 4238 10.1242/dev.059261 21068060
10. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Fantin A, Vieira JM, Gestri G, Denti L, Schwarz Q, Prykhozhij S, Peri F, Wilson SW, Ruhrberg C, Blood 2010 116 829 840 10.1182/blood-2009-12-257832 20404134
11. Insulin cell mass is altered in Csf1op/Csf1op macrophage-deficient mice. Banaei-Bouchareb L, Gouon-Evans V, Samara-Boustani D, Castellotti MC, Czernichow P, Pollard JW, Polak M, J Leukoc Biol 2004 76 359 367 10.1189/jlb.1103591 15178709 (Pubitemid 39006949)
12. The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: Evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification. Van Wesenbeeck L, Odgren PR, MacKay CA, D'Angelo M, Safadi FF, Popoff SN, Van Hul W, Marks SC, Proc Natl Acad Sci USA 2002 99 14303 14308 10.1073/pnas.202332999 12379742 (Pubitemid 35257667)
13. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B, J Exp Med 2007 204 1057 1069 10.1084/jem.20070075 17485518 (Pubitemid 46798150)
14. Macrophage Wnt7b is critical for kidney repair and regeneration. Lin SL, Li B, Rao S, Yeo EJ, Hudson TE, Nowlin BT, Pei H, Chen L, Zheng JJ, Carroll TJ, et al. Proc Natl Acad Sci USA 2010 107 4194 4199 10.1073/pnas.0912228107 20160075
15. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP, J Clin Invest 2005 115 56 65 15630444 (Pubitemid 40385505)
16. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. Pucci F, Venneri MA, Biziato D, Nonis A, Moi D, Sica A, Di Serio C, Naldini L, De Palma M, Blood 2009 114 901 914 10.1182/blood-2009-01-200931 19383967
17. Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation. Gordon EJ, Rao S, Pollard JW, Nutt SL, Lang RA, Harvey NL, Development 2010 137 3899 3910 10.1242/dev.050021 20978081
18. Blood monocytes consist of two principal subsets with distinct migratory properties. Geissmann F, Jung S, Littman DR, Immunity 2003 19 71 82 10.1016/S1074-7613(03)00174-2 12871640 (Pubitemid 36859902)
19. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, Naldini L, Cancer Cell 2005 8 211 226 10.1016/j.ccr.2005.08.002 16169466 (Pubitemid 41317592)
20. Exploring the full spectrum of macrophage activation. Mosser DM, Edwards JP, Nat Rev Immunol 2008 8 958 969 10.1038/nri2448 19029990
21. Alternative activation of macrophages: mechanism and functions. Gordon S, Martinez FO, Immunity 2010 32 593 604 10.1016/j.immuni.2010.05.007 20510870
22. Obligatory participation of macrophages in an angiopoietin 2-mediated cell death switch. Rao S, Lobov IB, Vallance JE, Tsujikawa K, Shiojima I, Akunuru S, Walsh K, Benjamin LE, Lang RA, Development 2007 134 4449 4458 10.1242/dev.012187 18039971
23. A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures. Rymo SF, Gerhardt H, Wolfhagen Sand F, Lang R, Uv A, Betsholtz C, PLoS One 2011 6 e15846 10.1371/journal.pone. 0015846 21264342
24. Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Stefater JA, Lewkowich I, Rao S, Mariggi G, Carpenter AC, Burr AR, Fan J, Ajima R, Molkentin JD, Williams BO, et al. Nature 2011 474 511 515 10.1038/nature10085 21623369
25. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S, Chimenti S, Landsman L, Abramovitch R, Keshet E, Cell 2006 124 175 189 10.1016/j.cell.2005.10.036 16413490 (Pubitemid 43069318)
26. Vascular-leukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro. Hazan AD, Smith SD, Jones RL, Whittle W, Lye SJ, Dunk CE, Am J Pathol 2010 177 1017 1030 10.2353/ajpath.2010.091105 20558572
27. Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Moldovan NI, Goldschmidt-Clermont PJ, Parker-Thornburg J, Shapiro SD, Kolattukudy PE, Circ Res 2000 87 378 384 10.1161/01.RES.87.5.378 10969035
28. Three pathways to mature macrophages in the early mouse yolk sac. Bertrand JY, Jalil A, Klaine M, Jung S, Cumano A, Godin I, Blood 2005 106 3004 3011 10.1182/blood-2005-02-0461 16020514 (Pubitemid 41565892)
29. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, Mehler MF, Conway SJ, Ng LG, Stanley ER, et al. Science 2010 330 841 845 10.1126/science.1194637 20966214
30. Prox1 function is required for the development of the murine lymphatic system. Wigle JT, Oliver G, Cell 1999 98 769 778 10.1016/S0092-8674(00)81511-1 10499794 (Pubitemid 29446894)
31. Segmental territories along the cardinal veins generate lymph sacs via a ballooning mechanism during embryonic lymphangiogenesis in mice. Francois M, Short K, Secker GA, Combes A, Schwarz Q, Davidson TL, Smyth I, Hong YK, Harvey NL, Koopman P, Dev Biol 2012 364 89 98 10.1016/j.ydbio.2011.12.032 22230615
32. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, et al. Nat Immunol 2004 5 74 80 10.1038/ni1013 14634646 (Pubitemid 38081471)
33. Sox18 induces development of the lymphatic vasculature in mice. Francois M, Caprini A, Hosking B, Orsenigo F, Wilhelm D, Browne C, Paavonen K, Karnezis T, Shayan R, Downes M, et al. Nature 2008 456 643 647 10.1038/nature07391 18931657
34. The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Srinivasan RS, Geng X, Yang Y, Wang Y, Mukatira S, Studer M, Porto MP, Lagutin O, Oliver G, Genes Dev 2010 24 696 707 10.1101/gad.1859310 20360386
35. Lymphangiogenesis: Molecular mechanisms and future promise. Tammela T, Alitalo K, Cell 2010 140 460 476 10.1016/j.cell.2010.01.045 20178740
36. Current views on the function of the lymphatic vasculature in health and disease. Wang Y, Oliver G, Genes Dev 2010 24 2115 2126 10.1101/gad.1955910 20889712
37. A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Ny A, Koch M, Schneider M, Neven E, Tong RT, Maity S, Fischer C, Plaisance S, Lambrechts D, Heligon C, et al. Nat Med 2005 11 998 1004 16116431 (Pubitemid 41294447)
38. Mesenchymal cells with leukocyte and lymphendothelial characteristics in murine embryos. Buttler K, Kreysing A, von Kaisenberg CS, Schweigerer L, Gale N, Papoutsi M, Wilting J, Dev Dyn 2006 235 1554 1562 10.1002/dvdy.20737 16502417 (Pubitemid 43787957)
39. Dual origin of avian lymphatics. Wilting J, Aref Y, Huang R, Tomarev SI, Schweigerer L, Christ B, Valasek P, Papoutsi M, Dev Biol 2006 292 165 173 10.1016/j.ydbio.2005.12.043 16457798
40. Proliferating mesodermal cells in murine embryos exhibiting macrophage and lymphendothelial characteristics. Buttler K, Ezaki T, Wilting J, BMC Dev Biol 2008 8 43 10.1186/1471-213X-8-43 18430230 (Pubitemid 351678107)
41. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Srinivasan RS, Dillard ME, Lagutin OV, Lin FJ, Tsai S, Tsai MJ, Samokhvalov IM, Oliver G, Genes Dev 2007 21 2422 2432 10.1101/gad.1588407 17908929 (Pubitemid 47529372)
42. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Venneri MA, De Palma M, Ponzoni M, Pucci F, Scielzo C, Zonari E, Mazzieri R, Doglioni C, Naldini L, Blood 2007 109 5276 5285 10.1182/blood-2006-10-053504 17327411 (Pubitemid 46890548)
43. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. Kubota Y, Takubo K, Shimizu T, Ohno H, Kishi K, Shibuya M, Saya H, Suda T, J Exp Med 2009 206 1089 1102 10.1084/jem.20081605 19398755
44. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW, Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER, Proc Natl Acad Sci USA 1990 87 4828 4832 10.1073/pnas.87.12.4828 2191302 (Pubitemid 20204197)
45. Regulation of developmental lymphangiogenesis by Syk(+) leukocytes. Bohmer R, Neuhaus B, Buhren S, Zhang D, Stehling M, Bock B, Kiefer F, Dev Cell 2010 18 437 449 10.1016/j.devcel.2010.01.009 20230750
46. The development of functional B lymphocytes in conditional PU.1 knock-out mice. Polli M, Dakic A, Light A, Wu L, Tarlinton DM, Nutt SL, Blood 2005 106 2083 2090 10.1182/blood-2005-01-0283 15933053 (Pubitemid 41291723)
47. Conditional deletion of the colony stimulating factor-1 receptor (c-fms proto-oncogene) in mice. Li J, Chen K, Zhu L, Pollard JW, Genesis 2006 44 328 335 10.1002/dvg.20219 16823860 (Pubitemid 44182449)
48. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, Jeltsch M, Petrova TV, Pytowski B, Stacker SA, et al. J Clin Invest 2005 115 247 257 15668734 (Pubitemid 40385467)
49. Critical role of CD11b+macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, Baik JE, Han SH, Alitalo K, Koh GY, Blood 2009 113 5650 5659 10.1182/blood-2008-09-176776 19346498
50. An important role of lymphatic vessel activation in limiting acute inflammation. Huggenberger R, Siddiqui SS, Brander D, Ullmann S, Zimmermann K, Antsiferova M, Werner S, Alitalo K, Detmar M, Blood 2011 117 4667 4678 10.1182/blood-2010-10-316356 21364190
51. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. Kerjaschki D, Regele HM, Moosberger I, Nagy-Bojarski K, Watschinger B, Soleiman A, Birner P, Krieger S, Hovorka A, Silberhumer G, et al. J Am Soc Nephrol 2004 15 603 612 10.1097/01.ASN.0000113316.52371.2E 14978162 (Pubitemid 38294790)
52. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival. Yin N, Zhang N, Xu J, Shi Q, Ding Y, Bromberg JS, Transplantation 2011 92 25 30 10.1097/TP.0b013e31821d2661 21508896
53. Clinicopathological correlation analysis of (lymph) angiogenesis and corneal graft rejection. Zheng Y, Lin H, Ling S, Mol Vis 2011 17 1694 1700 21738399
54. Role of CD11b+macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm. Kim KE, Koh YJ, Jeon BH, Jang C, Han J, Kataru RP, Schwendener RA, Kim JM, Koh GY, Am J Pathol 2009 175 1733 1745 10.2353/ajpath.2009.090133 19762711
55. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. Maruyama K, Ii M, Cursiefen C, Jackson DG, Keino H, Tomita M, Van Rooijen N, Takenaka H, D'Amore PA, Stein-Streilein J, et al. J Clin Invest 2005 115 2363 2372 10.1172/JCI23874 16138190 (Pubitemid 41266198)
56. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA, Am J Pathol 2007 170 1178 1191 10.2353/ajpath.2007.060018 17392158 (Pubitemid 47339326)
57. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Kerjaschki D, Huttary N, Raab I, Regele H, Bojarski-Nagy K, Bartel G, Krober SM, Greinix H, Rosenmaier A, Karlhofer F, et al. Nat Med 2006 12 230 234 10.1038/nm1340 16415878 (Pubitemid 43214751)
58. The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages. Maruyama K, Nakazawa T, Cursiefen C, Maruyama Y, Van Rooijen N, D'Amore PA, Kinoshita S, Invest Ophthalmol Vis Sci 2012 53 3145 3153 10.1167/iovs.11-8010 22511631
59. Increased lymphangiogenesis in joints of mice with inflammatory arthritis. Zhang Q, Lu Y, Proulx ST, Guo R, Yao Z, Schwarz EM, Boyce BF, Xing L, Arthritis Res Ther 2007 9 R118 10.1186/ar2326 17997858 (Pubitemid 350263553)
60. Lymphangiogenesis is required for pancreatic islet inflammation and diabetes. Yin N, Zhang N, Lal G, Xu J, Yan M, Ding Y, Bromberg JS, PLoS One 2011 6 e28023 10.1371/journal.pone.0028023 22132197
61. Inflammation-driven Dermal Lymphangiogenesis in Atopic Dermatitis is Associated with CD11b+ Macrophage Recruitment and VEGF-C Up-regulation in the IL-4-Transgenic Mouse Model. Shi VY, Bao L, Chan LS, Microcirculation in press
62. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, Park JK, Beck FX, Muller DN, Derer W, et al. Nat Med 2009 15 545 552 10.1038/nm.1960 19412173
63. Podoplanin-expressing cells derived from bone marrow play a crucial role in postnatal lymphatic neovascularization. Lee JY, Park C, Cho YP, Lee E, Kim H, Kim P, Yun SH, Yoon YS, Circulation 2010 122 1413 1425 10.1161/CIRCULATIONAHA. 110.941468 20855662
64. New model of macrophage acquisition of the lymphatic endothelial phenotype. Hall KL, Volk-Draper LD, Flister MJ, Ran S, PLoS One 2012 7 e31794 10.1371/journal.pone.0031794 22396739
65. Myeloid cells contribute to tumor lymphangiogenesis. Zumsteg A, Baeriswyl V, Imaizumi N, Schwendener R, Ruegg C, Christofori G, PLoS One 2009 4 e7067 10.1371/journal.pone.0007067 19759906
66. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Schoppmann SF, Birner P, Stockl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D, Am J Pathol 2002 161 947 956 10.1016/S0002-9440(10)64255-1 12213723 (Pubitemid 34988382)
67. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, D'Amore PA, Dana MR, Wiegand SJ, Streilein JW, J Clin Invest 2004 113 1040 1050 15057311 (Pubitemid 38544126)
68. Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+macrophages in advanced ovarian cancer. Jeon BH, Jang C, Han J, Kataru RP, Piao L, Jung K, Cha HJ, Schwendener RA, Jang KY, Kim KS, et al. Cancer Res 2008 68 1100 1109 10.1158/0008-5472.CAN-07-2572 18281485 (Pubitemid 351272228)
69. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Kunstfeld R, Hirakawa S, Hong YK, Schacht V, Lange-Asschenfeldt B, Velasco P, Lin C, Fiebiger E, Wei X, Wu Y, et al. Blood 2004 104 1048 1057 10.1182/blood-2003-08-2964 15100155 (Pubitemid 39038025)
70. Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes. Cursiefen C, Maruyama K, Bock F, Saban D, Sadrai Z, Lawler J, Dana R, Masli S, J Exp Med 2011 208 1083 1092 10.1084/jem.20092277 21536744
71. B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis. Ruddell A, Mezquita P, Brandvold KA, Farr A, Iritani BM, Am J Pathol 2003 163 2233 2245 10.1016/S0002-9440(10)63581-X 14633598 (Pubitemid 37466468)
72. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Angeli V, Ginhoux F, Llodra J, Quemeneur L, Frenette PS, Skobe M, Jessberger R, Merad M, Randolph GJ, Immunity 2006 24 203 215 10.1016/j.immuni.2006.01.003 16473832 (Pubitemid 43214589)
73. T lymphocytes negatively regulate lymph node lymphatic vessel formation. Kataru RP, Kim H, Jang C, Choi DK, Koh BI, Kim M, Gollamudi S, Kim YK, Lee SH, Koh GY, Immunity 2011 34 96 107 10.1016/j.immuni.2010.12.016 21256057
74. Focus on lymphangiogenesis in tumor metastasis. Achen MG, McColl BK, Stacker SA, Cancer Cell 2005 7 121 127 10.1016/j.ccr.2005.01.017 15710325 (Pubitemid 40248338)
75. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor heparin-binding domain fusion proteins. Tammela T, He Y, Lyytikka J, Jeltsch M, Markkanen J, Pajusola K, Yla-Herttuala S, Alitalo K, Circ Res 2007 100 1468 1475 10.1161/01.RES.0000269043.51272.6d 17478733 (Pubitemid 46834759)
76. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, Harding T, Jooss K, Takahashi T, Alitalo K, Cancer Res 2005 65 4739 4746 10.1158/0008-5472.CAN-04-4576 15930292 (Pubitemid 40740810)
77. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer. Yang H, Kim C, Kim MJ, Schwendener RA, Alitalo K, Heston W, Kim I, Kim WJ, Koh GY, Mol Cancer 2011 10 36 10.1186/1476-4598-10-36 21481239
78. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma. Zhang B, Wang J, Gao J, Guo Y, Chen X, Wang B, Gao J, Rao Z, Chen Z, J Cell Biochem 2009 107 134 143 10.1002/jcb.22110 19241443
79. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Schoppmann SF, Fenzl A, Nagy K, Unger S, Bayer G, Geleff S, Gnant M, Horvat R, Jakesz R, Birner P, Surgery 2006 139 839 846 10.1016/j.surg.2005.12.008 16782443 (Pubitemid 43902914)
80. The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C. Moussai D, Mitsui H, Pettersen JS, Pierson KC, Shah KR, Suarez-Farinas M, Cardinale IR, Bluth MJ, Krueger JG, Carucci JA, J Invest Dermatol 2011 131 229 236 10.1038/jid.2010.266 20827282
81. Type and location of tumor-infiltrating macrophages and lymphatic vessels predict survival of colorectal cancer patients. Algars A, Irjala H, Vaittinen S, Huhtinen H, Sundstrom J, Salmi M, Ristamaki R, Jalkanen S, Int J Cancer 2011 131 864 873 21952788
82. VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Karnezis T, Shayan R, Caesar C, Roufail S, Harris NC, Ardipradja K, Zhang YF, Williams SP, Farnsworth RH, Chai MG, et al. Cancer Cell 2012 21 181 195 10.1016/j.ccr.2011.12.026 22340592